Trial record 1 of 1 for:
NCT04360265
A Long-term Follow-up Study of Patients With MPS IIIA Treated With ABO-102
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04360265 |
|
Recruitment Status :
Enrolling by invitation
First Posted : April 24, 2020
Last Update Posted : May 14, 2024
|
Sponsor:
Ultragenyx Pharmaceutical Inc
Collaborator:
Abeona Therapeutics, Inc
Information provided by (Responsible Party):
Ultragenyx Pharmaceutical Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Enrolling by invitation |
|---|---|
| Estimated Primary Completion Date : | June 2027 |
| Estimated Study Completion Date : | June 2027 |